Drug Profile
Testosterone injection - Lawley Pharmaceuticals
Latest Information Update: 07 Jan 2022
Price :
$50
*
At a glance
- Originator Lawley Pharmaceuticals
- Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease
Most Recent Events
- 23 Mar 2018 Lawley Pharmaceuticals withdraws phase II trial in Alzheimer's disease (In the elderly, Prevention) prior to enrolment in Australia (IM) (ACTRN12613000034730)